Merck & Co., Inc.

Equities

MRK

US58933Y1055

Market Closed - Nyse Other stock markets 21:00:02 15/05/2026 BST			5-day change	1st Jan Change
111.38 ^USD	-1.79%		0.00%	+5.81%

05-15	Mubadala Investment Co PJSC reports share stake in Apple, Medtronic, Broadcom	RE
05-13	European shares lifted by miners and tech; Mideast in focus	RE

Transcript : Merck & Co., Inc. Presents at Evercore 8th Annual Healthcare Conference, Dec-02-2025 09

Published on 12/02/2025 at 04:20 pm GMT - Modified on 12/03/2025 at 09:06 am GMT

S&P Capital IQ

Presenter Speech
Umer Raffat (Analysts)

All right. Fantastic. So we'll jump right in. I want to do R&D and commercial. Do we have a preference where we should start? Okay. We'll start maybe a little

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about Merck & Co., Inc.

05-15	Mubadala Investment Co PJSC reports share stake in Apple, Medtronic, Broadcom	RE
05-13	European shares lifted by miners and tech; Mideast in focus	RE
05-12	Merck highlights new long-term data and advancements across broad oncology portfolio and pipeline research at Asco 2026	RE
05-12	Merck Highlights New Long-Term Data and Advancements Across Broad Oncology Portfolio and Pipeline Research At Asco 2026	CI
05-11	Erasca Teams With Merck on AURORAS-1 Cancer Study	MT
05-11	Erasca, Inc. Announces Clinical Trial Collaboration and Supply Agreement with Merck to Evaluate ERAS-0015 in Combination with KEYTRUDA (Pembrolizumab)	CI
05-07	The Rally Spreads
05-05	Merck Completes Terns Pharmaceuticals Acquisition	MT
05-04	Global pharma companies that have publicly announced Trump drug pricing agreements	RE
05-01	Goldman Sachs Adjusts Merck Price Target to $137 From $133	MT
05-01	Wells Fargo Adjusts Merck Price Target to $145 From $150	MT
05-01	Big Pharma M&A set for mega year as patent expiries drive deal urgency	RE
05-01	Morgan Stanley Raises Price Target on Merck to $112 From $109, Keeps Equalweight Rating	MT
05-01	Moderna first-quarter revenue jumps on strong overseas COVID vaccine sales	RE
04-30	S&P 500, Nasdaq on course for best month since 2020 despite Middle East risks	RE